SynAct Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	53.41	61.21	62.4	108.25	24
Cash & Short-Term Investments	53.41	61.21	62.4	108.25	24
Cash Growth	-12.75%	-1.90%	-42.36%	351.08%	64.95%
Other Receivables	13.38	14.43	12.41	14.7	10.67
Receivables	13.38	14.43	12.41	14.7	10.67
Prepaid Expenses	4.56	18.37	0.26	17.29	0.25
Other Current Assets	-0	-0	-0	-0	0
Total Current Assets	71.35	94	75.06	140.23	34.92
Property, Plant & Equipment	1.21	1.94	0.66	2.1	3.18
Long-Term Investments	-	0.05	0.14	0.27	0.27
Long-Term Deferred Charges	147.82	154.59	152.16	-	-
Other Long-Term Assets	0.14	19.94	0	-	-
Total Assets	220.52	270.52	228.02	142.6	38.37
Accounts Payable	9.49	17.35	9.67	4.72	4.25
Accrued Expenses	11.14	10.09	9.82	4.91	7.89
Current Portion of Leases	0.62	0.6	0.58	1	0.98
Other Current Liabilities	0.28	0.42	4.88	4.38	2.27
Total Current Liabilities	21.52	28.46	24.94	15.01	15.39
Long-Term Leases	0.6	1.29	0.06	1.06	2.11
Long-Term Deferred Tax Liabilities	17.5	18.3	18.02	-	-
Other Long-Term Liabilities	10.61	8.3	8.82	-	-
Total Liabilities	50.23	56.35	51.83	16.08	17.5
Common Stock	6.67	5.81	4.45	3.71	3.25
Additional Paid-In Capital	835.34	762.8	646.57	394.84	193.6
Retained Earnings	-683.83	-573	-490.6	-274.79	-175.59
Comprehensive Income & Other	12.11	18.56	15.77	2.77	-0.4
Shareholders' Equity	170.29	214.17	176.19	126.52	20.87
Total Liabilities & Equity	220.52	270.52	228.02	142.6	38.37
Total Debt	1.21	1.88	0.64	2.06	3.09
Net Cash (Debt)	52.2	59.33	61.76	106.18	20.91
Net Cash Growth	-12.02%	-3.94%	-41.84%	407.85%	43.72%
Net Cash Per Share	1.02	1.50	1.90	3.85	0.81
Filing Date Shares Outstanding	53.33	46.49	35.57	31.82	26.01
Total Common Shares Outstanding	53.33	46.49	35.57	29.65	26.01
Working Capital	49.82	65.54	50.12	125.22	19.53
Book Value Per Share	3.19	4.61	4.95	4.27	0.80
Tangible Book Value	170.29	214.17	176.19	126.52	20.87
Tangible Book Value Per Share	3.19	4.61	4.95	4.27	0.80

Source: S&P Global Market Intelligence. Standard template. Financial Sources.